Not finding it? Sign in to also search OpenAlex live.
-
Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access
Suzanne M. Castenmiller, Nandhini Kanagasabesan, Aurélie Guislain, Benoît P. Nicolet, Marleen M. van Loenen, Kim Monkhorst, +6 more
0citations -
Establishing a Fetal Lamb Model for Hypoplastic Left Heart Syndrome—A Feasibility Pilot Study2024 The Thoracic and Cardiovascular Surgeon conference-paper Medicine Congenital Heart Disease Studies
Walter Knirsch, Monique C. Haak, EDGAR T. JAEGGI, Mike Seed, Ahmed Abdelhamed Hassan, Bernard D. Krüger, +4 more
0citations -
NanoDesigner: Resolving the complex–CDR interdependency with iterative refinement2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Monoclonal and Polyclonal Antibodies Research Open access
Melissa Maria Rios Zertuche, Şenay Kafkas, Dominik Renn, Magnus Rueping, Robert Hoehndorf
0citations -
CORR Insights®: What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?0citations
-
Dynamic Exchange in 3D Cell Culture Hydrogels Based on Crosslinking of Cyclic Thiosulfinates2023 Angewandte Chemie article Biochemistry, Genetics and Molecular Biology Hydrogels: synthesis, properties, applications Open access
Merel L. Janssen, Tingxian Liu, Mertcan Özel, Maaike Bril, Hari Veera Prasad Thelu, Roxanne E. Kieltyka
0citations -
Phase III Randomized COMMODORE 1 Trial: 2-Year Safety and Efficacy of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Switched from Eculizumab2024 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Phillip Scheinberg, Diego V. Clé, Bérangère Devalet, Valentina Giai, Cristina Barrenetxea Lekue, Hsuan‐Yu Lin, +12 more
0citations -
P191 Efficacy and improvement in patient-reported outcomes at weeks 16 and 52 in ixekizumab treated biological naïve patients with radiographic axial spondyloarthritis achieving clinically important pain at night reduction at week 16: results from COAST-V trial
Sofía Ramiro, Cédric Lukas, Michael John Nissen, Yves Schymura, Khai Jing Ng, Gabriel Doridot, +3 more
0citations -
Durvalumab and tremelimumab versus doxorubicin in previously untreated patients with advanced or metastatic soft tissue sarcoma: Patient-reported outcomes (PROs) of the randomized phase II MEDISARC study (AIO-STS-0415).
Viktor Grünwald, Sebastian Bauer, Rainer Hamacher, Daniel Pink, Lars Hartwin Lindner, Stefan Gröschel, +8 more
0citations -
Quality of life after immune suppressive therapy in aplastic anemia2024 Annals of Hematology article Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access
Iris N. Lommerse, Chris Hinnen, Liesbeth Mirjam van Vliet, Beke Schubert, Jens Panse, Constantijn J.M. Halkes, +1 more
0citations -
Opening the Black Box: Towards inherently interpretable energy data imputation models using building physics insight2023 arXiv (Cornell University) preprint Engineering Building Energy and Comfort Optimization Open access
Antonio Liguori, Matías Quintana, Chun Fu, Clayton Carl Miller, Jérôme Frisch, Christoph van Treeck
0citations -
Temperature dependence of the magnon-phonon interaction in high overtone bulk acoustic resonator-ferromagnetic thin film hybrids2023 RWTH Publications (RWTH Aachen) preprint Physics and Astronomy Mechanical and Optical Resonators Open access
Manuel Müller, Sebastian T. B. Goennenwein, Silvia Viola Kusminskiy, Rudolf Groß, Matthias Althammer, Hans Huebl
0citations -
Serum levels of CXCL13 are an independent predictor of survival following resection of biliary tract cancer2020 Zeitschrift für Gastroenterologie conference-paper Medicine Cholangiocarcinoma and Gallbladder Cancer Studies
SH Loosen, AA Roeth, PH Alizai, Jan Bednarsch, Mihael Vucur, TF Ulmer, +4 more
0citations